Publications by authors named "Congming Xiang"

Claim this Profile
P
Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis.
Chengwen Sun, Xiaoxiao Sun, Yougan Chen, Yuwei Wu, Congming Xiang

BMC Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsa_circ_0030568 Promotes the Proliferation and Migration of Prostate Cancer Cells via the miR-141-3p-BRD4 Axis.
Xiaoxiao Sun, Congming Xiang, Yuwei Wu, Dongsheng Ge, Chengwen Sun

Comb Chem High Throughput Screen· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Chengwen Sun, Dongrong Yang, Jin Zhu, Yibin Zhou, Congming Xiang

BMC Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
Yougan Chen, Yuanyuan Deng, Chenyao Zhu, Congming Xiang

Biomed Pharmacother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
Chengwen Sun, Caihong Sun, Yibin Zhou, Ganglong Yang, Guang Li, Congming Xiang

Mol Med Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis